121 related articles for article (PubMed ID: 4144372)
1. Electrophysiological evaluation of anesthetic actions of some beta-adrenergic blockers on guinea-pig cardiac muscles.
Washizu Y
Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):263-9. PubMed ID: 4144372
[No Abstract] [Full Text] [Related]
2. Cardiac toxicity of -lytic drugs.
Roba J
Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
[No Abstract] [Full Text] [Related]
3. The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential).
Coltart DJ; Meldrum SJ
Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):188-97. PubMed ID: 4398411
[No Abstract] [Full Text] [Related]
4. Antisympathomimetic effects of Kö 1313 and Kö 1366 in guinea-pig atria.
Ban T
Jpn J Pharmacol; 1973 Apr; 23(2):251-8. PubMed ID: 4147484
[No Abstract] [Full Text] [Related]
5. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
Cheymol G; Honnorat C; Schmitt H
Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
[No Abstract] [Full Text] [Related]
6. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
Marmo E; Caputi AP; Saini RK
Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
[No Abstract] [Full Text] [Related]
7. Salivation in mice as an index of adrenergic activity. I. Salivation and temperature responses to d-amphetamine and other sialogogues and the effects of adrenergic blocking agents.
Maling HM; Williams MA; Koppanyi T
Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):318-32. PubMed ID: 4403618
[No Abstract] [Full Text] [Related]
8. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
Nayler WG; Tay J
J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
[No Abstract] [Full Text] [Related]
9. Guinea-pig atrial and pulmonary beta-adrenoceptors.
Spilker BA; McKeon WB; Arnold A
Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):220-30. PubMed ID: 4151237
[No Abstract] [Full Text] [Related]
10. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
Giudicelli JF; Boissier JR
Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
[No Abstract] [Full Text] [Related]
11. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
Range H; Bischoff M; Siess M
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
[No Abstract] [Full Text] [Related]
12. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
Grün G; Byon KY; Kaufmann R; Fleckenstein A
Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
[No Abstract] [Full Text] [Related]
13. Effect of propranolol upon the hemoglobin-oxygen dissociation curve.
Pendleton RG; Newman DJ; Sherman SS; Brann EG; Maya WE
J Pharmacol Exp Ther; 1972 Mar; 180(3):647-56. PubMed ID: 4401159
[No Abstract] [Full Text] [Related]
14. [Modifications of the electric activity of the guinea pig myocardial fiber induced by 4 stereoisomers of butidrine, a new compound with adrenergic beta receptor blockading action].
Musso E; Taccardi B
Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):173-89. PubMed ID: 4392359
[No Abstract] [Full Text] [Related]
15. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
Nakanishi M; Imamura H; Nakamura T; Kimura T
Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
[No Abstract] [Full Text] [Related]
16. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
Marmo E; Saini RK; Caputi AP
Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
[No Abstract] [Full Text] [Related]
17. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
[No Abstract] [Full Text] [Related]
18. [Phenbutolol (Hoe 893d), a new highly efficient -sympatholytic agent with long action duration].
Härtfelder G; Lessenich H; Schmitt K
Arzneimittelforschung; 1972 May; 22(5):930-2. PubMed ID: 4403127
[No Abstract] [Full Text] [Related]
19. [Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
Cheymol G; Mouillé P; Laubie M; Schmitt H
C R Seances Soc Biol Fil; 1972; 166(6):823-8. PubMed ID: 4143908
[No Abstract] [Full Text] [Related]
20. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
Bassenge E; Kucharczyk M; Holtz J; Stoian D
Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
